Bengt Sparf

1.1k total citations
15 papers, 874 citations indexed

About

Bengt Sparf is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Urology. According to data from OpenAlex, Bengt Sparf has authored 15 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 3 papers in Urology. Recurrent topics in Bengt Sparf's work include Receptor Mechanisms and Signaling (6 papers), Ion channel regulation and function (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Bengt Sparf is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Ion channel regulation and function (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Bengt Sparf collaborates with scholars based in Sweden. Bengt Sparf's co-authors include Lisbeth Nilvebrant, J. Schüberth, A. Sundwall, Matthias Stahl, K. Andersson, Per‐Göran Gillberg, Björn Ekström, Anders Mattiasson, Karl‐Erik Andersson and Sten‐Magnus Aquilonius and has published in prestigious journals such as Journal of Neurochemistry, The Journal of Urology and European Journal of Pharmacology.

In The Last Decade

Bengt Sparf

15 papers receiving 809 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bengt Sparf 344 322 291 207 180 15 874
Patrizia Angelico 266 0.8× 196 0.6× 210 0.7× 74 0.4× 50 0.3× 27 620
Steven A. Buckner 335 1.0× 154 0.5× 434 1.5× 59 0.3× 58 0.3× 57 986
William A. Carroll 97 0.3× 251 0.8× 501 1.7× 31 0.1× 75 0.4× 44 1.5k
Barry Kenny 236 0.7× 324 1.0× 595 2.0× 23 0.1× 34 0.2× 19 951
A.V. Daza 188 0.5× 170 0.5× 253 0.9× 40 0.2× 32 0.2× 22 658
Elena Poggesi 284 0.8× 484 1.5× 746 2.6× 50 0.2× 36 0.2× 54 1.5k
Rodolfo Testa 176 0.5× 182 0.6× 280 1.0× 40 0.2× 35 0.2× 34 617
Michael E. Brune 182 0.5× 83 0.3× 251 0.9× 38 0.2× 54 0.3× 41 746
K P Minneman 172 0.5× 427 1.3× 696 2.4× 25 0.1× 28 0.2× 14 1.0k
Kristi L. Whiteaker 95 0.3× 142 0.4× 249 0.9× 20 0.1× 21 0.1× 21 584

Countries citing papers authored by Bengt Sparf

Since Specialization
Citations

This map shows the geographic impact of Bengt Sparf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Sparf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Sparf more than expected).

Fields of papers citing papers by Bengt Sparf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Sparf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Sparf. The network helps show where Bengt Sparf may publish in the future.

Co-authorship network of co-authors of Bengt Sparf

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Sparf. A scholar is included among the top collaborators of Bengt Sparf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Sparf. Bengt Sparf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Nilvebrant, Lisbeth, et al.. (1998). Tolterodine-A New Bladder-Selective Antimuscarinic Agent. The Journal of Urology. 160(3 Part 1). 964–964. 4 indexed citations
2.
Nilvebrant, Lisbeth, Per‐Göran Gillberg, & Bengt Sparf. (1997). Antimuscarinic Potency and Bladder Selectivity of PNU‐200577, a Major Metabolite of Tolterodine. Pharmacology & Toxicology. 81(4). 169–172. 84 indexed citations
3.
Nilvebrant, Lisbeth, et al.. (1997). Tolterodine – a new bladder-selective antimuscarinic agent. European Journal of Pharmacology. 327(2-3). 195–207. 244 indexed citations
4.
Stahl, Matthias, Björn Ekström, Bengt Sparf, Anders Mattiasson, & Karl‐Erik Andersson. (1995). Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivity. Neurourology and Urodynamics. 14(6). 647–655. 82 indexed citations
5.
Nilvebrant, Lisbeth & Bengt Sparf. (1988). Receptor binding profiles of some selective muscarinic antagonists. European Journal of Pharmacology. 151(1). 83–96. 30 indexed citations
6.
Nilvebrant, Lisbeth & Bengt Sparf. (1986). Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites. European Journal of Pharmacology. 123(1). 133–143. 68 indexed citations
7.
Nilvebrant, Lisbeth & Bengt Sparf. (1983). Muscarinic Receptor Binding in the Guinea Pig Urinary Bladder. Acta Pharmacologica et Toxicologica. 52(1). 30–38. 35 indexed citations
8.
Nilvebrant, Lisbeth & Bengt Sparf. (1983). Differences between Binding Affinities of some Antimuscarinic Drugs in the Parotid Gland and those in the Urinary Bladder and Ileum. Acta Pharmacologica et Toxicologica. 53(4). 304–313. 45 indexed citations
9.
Nilvebrant, Lisbeth & Bengt Sparf. (1982). Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.. PubMed. 72. 69–77. 16 indexed citations
10.
Sparf, Bengt, et al.. (1978). Differences in postsynaptic α‐Adrenoceptor Populations Between Isolated Cat Urethra and Various Other Isolated Tissues.. Acta Pharmacologica et Toxicologica. 43(s1). 48–55. 7 indexed citations
11.
Sparf, Bengt, et al.. (1975). The effect of atropine on the turnover of acetylcholine in the mouse brain. European Journal of Pharmacology. 32(2). 287–292. 17 indexed citations
12.
Aquilonius, Sten‐Magnus, F. Flentge, J. Schüberth, Bengt Sparf, & A. Sundwall. (1973). SYNTHESIS OF ACETYLCHOLINE IN DIFFERENT COMPARTMENTS OF BRAIN NERVE TERMINALS IN VIVO AS STUDIED BY THE INCORPORATION OF CHOLINE FROM PLASMA AND THE EFFECT OF PENTOBARBITAL ON THIS PROCESS. Journal of Neurochemistry. 20(6). 1509–1521. 37 indexed citations
13.
Sparf, Bengt. (1973). On the turnover of acetylcholine in the brain. An experimental study using intravenously injected radioactive choline.. PubMed. 397. 1–47. 22 indexed citations
14.
Schüberth, J., Bengt Sparf, & A. Sundwall. (1970). ON THE TURNOVER OF ACETYLCHOLINE IN NERVE ENDINGS OF MOUSE BRAIN IN VIVO. Journal of Neurochemistry. 17(4). 461–468. 51 indexed citations
15.
Schüberth, J., Bengt Sparf, & A. Sundwall. (1969). A TECHNIQUE FOR THE STUDY OF ACETYLCHOLINE TURNOVER IN MOUSE BRAIN IN VIVO. Journal of Neurochemistry. 16(5). 695–700. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizia Angelico Breakdown of academic impact, for papers by Steven A. Buckner Breakdown of academic impact, for papers by William A. Carroll Breakdown of academic impact, for papers by Barry Kenny Breakdown of academic impact, for papers by A.V. Daza Breakdown of academic impact, for papers by Elena Poggesi Breakdown of academic impact, for papers by Rodolfo Testa Breakdown of academic impact, for papers by Michael E. Brune Breakdown of academic impact, for papers by K P Minneman Breakdown of academic impact, for papers by Kristi L. Whiteaker
Rankless by CCL
2026